- Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
Junichi Kato et al, 2019, Gastrointestinal Disorders CrossRef - Long-Term Administration of Omeprazole-Induced Hypergastrinemia and Changed Glucose Homeostasis and Expression of Metabolism-Related Genes
Alina Kabaliei et al, 2024, BioMed Research International CrossRef - Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2
Chen-Jie Qin et al, 2018, Cancer Letters CrossRef - CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
Monika Zajkowska et al, 2023, Scientific Reports CrossRef - The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway
Liang He et al, 2020, Medical Oncology CrossRef - Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis
AM Kabel et al, 2021, Human & Experimental Toxicology CrossRef - Dipeptidyl Peptidase (DPP)-4 Inhibitor Impairs the Outcomes of Patients with Type 2 Diabetes Mellitus After Curative Resection for Colorectal Cancer
Akira Saito et al, 2021, Cancer Research Communications CrossRef - CD26/DPP4 - a potential biomarker and target for cancer therapy
Njanja Enz et al, 2019, Pharmacology & Therapeutics CrossRef - Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
Qian Zou et al, 2022, Frontiers in Immunology CrossRef - Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus
Poonam Kalhotra et al, 2020, Biomolecules CrossRef - Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases
Eloisa Martins da Silva et al, 2022, Peptides CrossRef - Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
Petr Busek et al, 2022, Cancers CrossRef